BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/19/2020 4:08:52 PM | Browse: 528 | Download: 1208
 |
Received |
|
2020-07-27 13:17 |
|
Peer-Review Started |
|
2020-07-27 13:18 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-08-11 02:21 |
|
Revised |
|
2020-10-29 12:38 |
|
Second Decision |
|
2020-11-02 12:09 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-11-04 04:30 |
|
Articles in Press |
|
2020-11-04 04:30 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-12-02 05:42 |
|
Publish the Manuscript Online |
|
2020-12-19 16:08 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yoriaki Komeda, Toshiharu Sakurai, Kazuko Sakai, Yasuyoshi Morita, Arito Hashimoto, Tomoyuki Nagai, Satoru Hagiwara, Itaru Matsumura, Kazuto Nishio and Masatoshi Kudo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Toshiharu Sakurai, MD, PhD, Assistant Professor, Senior Lecturer, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka 589-8511, Japan. sakurai@med.kindai.ac.jp |
| Key Words |
Ulcerative colitis; Idiopathic thrombocytopenic purpura; Tofacitinib; Whole transcriptome analysis; Case report; Predictive biomarker |
| Core Tip |
We herein report a refractory case of ulcerative colitis associated with idiopathic thrombocytopenic purpura successfully treated with tofacitinib. The relationship between these two disease entities underscore treatment implications, given their potentially shared immunological pathway and responses to similar medications. To investigate changes in gene signatures during tofacitinib therapy, whole transcriptomic sequencing was performed for inflamed rectal mucosae obtained before and after the initiation of Janus kinase (JAK) inhibitor. Distinct molecular signatures seemed to be regulated by JAK inhibition and tumor necrosis factor blockade, suggesting that the identification of gene sets may be able to predict therapeutic responses to medications. |
| Publish Date |
2020-12-19 16:08 |
| Citation |
Komeda Y, Sakurai T, Sakai K, Morita Y, Hashimoto A, Nagai T, Hagiwara S, Matsumura I, Nishio K, Kudo M. Refractory case of ulcerative colitis with idiopathic thrombocytopenic purpura successfully treated by Janus kinase inhibitor tofacitinib: A case report. World J Clin Cases 2020; 8(24): 6389-6395 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i24/6389.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i24.6389 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
